Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide
Open Access
- 17 January 2019
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 37 (7), 991-1000
- https://doi.org/10.1016/j.vaccine.2018.12.061
Abstract
No abstract availableKeywords
Funding Information
- GlaxoSmithKline Biologicals SA
This publication has 37 references indexed in Scilit:
- Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)Vaccine, 2013
- Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverageVaccine, 2013
- Interlaboratory Standardization of the Sandwich Enzyme-Linked Immunosorbent Assay Designed for MATS, a Rapid, Reproducible Method for Estimating the Strain Coverage of Investigational VaccinesClinical and Vaccine Immunology, 2012
- The challenge of post-implementation surveillance for novel meningococcal vaccinesVaccine, 2012
- The use of vaccine antigen characterization, for example by MATS, to guide the introduction of meningococcus B vaccinesVaccine, 2012
- The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: Immunological, functional and structural characterization of the antigensVaccine, 2012
- BIGSdb: Scalable analysis of bacterial genome variation at the population levelBMC Bioinformatics, 2010
- Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccinesProceedings of the National Academy of Sciences of the United States of America, 2010
- Characterization of fHbp , nhba ( gna2132 ), nadA , porA , and Sequence Type in Group B Meningococcal Case Isolates Collected in England and Wales during January 2008 and Potential Coverage of an Investigational Group B Meningococcal VaccineClinical and Vaccine Immunology, 2010
- Neisseria meningitidis group B correlates of protection and assay standardization—International Meeting Report Emory University, Atlanta, Georgia, United States, 16–17 March 2005Vaccine, 2006